Hongfu Lu

8PUBLICATIONS
14CO-AUTHORS
Molecular targetsBiologically active moleculesCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 01, 2025
Design, Synthesis and Biological Evaluation of Novel, Potent, Selective and Orally Available DGKα Inhibitors for the Treatment of Tumors.

Hongfu Lu, Sujing Shi, Huaxing Yu

|Sep 08, 2025
Discovery of Novel, Potent, Selective, and Orally Available DGKα Inhibitors for the Treatment of Tumors.

Hongfu Lu, Deheng Sun, Haoyu Zhang

|Apr 10, 2025
Discovery of WEE1 Kinase Inhibitors with Potent Activity against Patient-Derived, Metastatic Colorectal Cancer Organoids.

Joel L Syphers, Josephine A Wright, Shen Liu

|Feb 14, 2025
Design, Synthesis, and Biological Evaluation of Novel Orally Available Covalent CDK12/13 Dual Inhibitors for the Treatment of Tumors.

Hongfu Lu, Deheng Sun, Zhen Wang

|Jan 09, 2025
Discovery of Potent, Highly Selective, and Orally Bioavailable MTA Cooperative PRMT5 Inhibitors with Robust In Vivo Antitumor Activity.

Meng Zhang, Xiaoyu Ding, Zhongying Cao

|Nov 25, 2024
Discovery of Pyridine-2-Carboxamides Derivatives as Potent and Selective HPK1 Inhibitors for the Treatment of Cancer.

Jingjing Peng, Xiaoyu Ding, Celia Xiaojing Chen

Pageof 2

Frequent Collaborators

7 joint publications

Xiao Ding

7 joint publications

Alex Aliper

7 joint publications

Feng Ren

7 joint publications

Alex Zhavoronkov